Targeting toll-like receptor 7 as a therapeutic development strategy for systemic lupus erythematosus.

导出 LinkOut

翻译打印收藏纠错

第一作者： Meng,Wang

第一单位： Toll Biotech Co., Ltd. (Beijing), Beijing 102209, China.

作者： Meng,Wang ^[1] ; Hekai,Chen ^[2] ; Tuan,Zhang ^[2] ; Zhikuan,Zhang ^[3] ; Xuwen,Xiang ^[1] ; Meng,Gao ^[1] ; Yilan,Guo ^[1] ; Shuangshuang,Jiang ^[2] ; Kejun,Yin ^[2] ; Mintao,Chen ^[2] ; Jian,Huang ^[2] ; Xincheng,Zhong ^[2] ; Umeharu,Ohto ^[3] ; Jing,Li ^[4] ; Toshiyuki,Shimizu ^[3] ; Hang,Yin ^[2]

作者单位： Toll Biotech Co., Ltd. (Beijing), Beijing 102209, China. ^[1] State Key Laboratory of Membrane Biology, School of Pharmaceutical Sciences, Tsinghua-Peking Center for Life Sciences, Key Laboratory of Bioorganic Phosphorous Chemistry and Chemical Biology (Ministry of Education), Tsinghua University, Beijing 100084, China. ^[2] Graduate School of Pharmaceutical Sciences, the University of Tokyo, Tokyo 113-0033, Japan. ^[3] Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100032, China. ^[4]

关键词 Atomistic resolution cryo-EM structure Cytokine MRL Resting state Selective Small-molecule inhibitor Systemic lupus erythematosus TLR7

DOI 10.1016/j.apsb.2024.08.016

PMID 39664432

发布时间 2024-12-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Acta pharmaceutica Sinica. B

2024年14卷11期

4899-4913页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Targeting toll-like receptor 7 as a therapeutic development strategy for systemic lupus erythematosus.

Acta pharmaceutica Sinica. B

相似文献

Acta pharmaceutica Sinica. B

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Targeting toll-like receptor 7 as a therapeutic development strategy for systemic lupus erythematosus.

Acta pharmaceutica Sinica. B

相似文献

Acta pharmaceutica Sinica. B

相关期刊

检索历史清除